Weight regain following GLP-1 discontinuation occurs gradually but consistently in most patients
We will either order labs for you or accept labs completed within 6 months prior to program enrollment
In this context, GLP-1R agonists show remarkable potential as an emerging therapeutic agent.GLP-1R agonists reduce body weight, lower blood pressure, and improve lipid levels, as well as exerting anti-inflammatory and antioxidant effects by directly acting on GLP-1R in the heart and blood vessels, thereby reducing the risk of atherosclerotic thrombotic events (Solini et al., 2023)
Impact on perioperative glycaemia Less hypoglycaemia risk than insulin and better perioperative glucose control
Updated February 2026 Retatrutide vs Wegovy: Triple Agonist vs GLP-1 Retatrutide produces nearly double the weight loss of Wegovy, but Wegovy is available now with proven cardiovascular protection
81,107,109 Tanzeum was discontinued by GlaxoSmithKline (GSK) in 2017, primarily due to economic factors
